In the face of global health crises, such as pandemics, the pharmaceutical supply chain becomes even more vulnerable to risks, including unpaid debts. These risks can have severe consequences, impacting the availability and affordability of essential medications. Therefore, it is crucial for pharmaceutical companies to adopt strategies that mitigate the…